-
Key Considerations in the Use of Large Language Models for Data Extraction in Health Economics and Outcomes Research
Mar 10, 2025, 14:00 PM -
Geographic Variation in Lower Limb Prosthesis Prescription Disparities Between White and Black Veterans: A Retrospective Cohort Analysis (2010 - 2022)
Mar 10, 2025, 14:00 PM -
US Food and Drug Administration Authorizations of Therapeutic Biologics and Biosimilars, 1980-2024
Mar 10, 2025, 14:00 PM -
US Physician Characteristics Associated With Real-World Evidence Implementation in Oncology Practice
Mar 10, 2025, 14:00 PM -
Association of Sleep Disturbances With Mild Cognitive Impairment Among Adults in the US
Mar 10, 2025, 14:00 PM -
Assessing Prescribing Trends for Select Glucagon-Like Peptide Receptor Agonists (GLP-1s) by Patient Demographics, Providers, and Indication
Mar 10, 2025, 14:00 PM -
Machine Learning for Predictive Modeling of Hospitalization Risk in Myasthenia Gravis Patients Using the MGFA Global Patient Registry: Addressing Imbalanced Data in Real-World Evidence Scenarios
Mar 10, 2025, 14:00 PM -
Real-World Treatment Patterns Among Patients With Scalp Psoriasis in Canada
Mar 10, 2025, 14:00 PM -
Household Costs and Other Societal Impacts for Individuals With Duchenne Muscular Dystrophy Stratified by Upper Limb Impairment: Results From a Caregiver Survey
Mar 10, 2025, 14:00 PM -
Differential Item Functioning With the National Eye Institute Visual Function Questionnaire-25 in Patients With Vitreomacular Traction
Mar 10, 2025, 14:00 PM -
From Data to Actionable Insight: A Collaborative Monitoring & Evaluation (M&E) Initiative Convened by Canada’s Drug Agency (CDA-AMC) - Piloting Plans for Diabetes and Contraception
Mar 10, 2025, 14:00 PM -
Considerations for Health Economic Modeling in Phenylketonuria (PKU): Insights From a Modified Delphi Panel
Mar 10, 2025, 14:00 PM -
Payer Archetypes and Decision-Making in the United States (US): A framework for Generalised Cost-Effectiveness Analysis (GCEA) Value Elements to Optimize Patient Access and Equity
Mar 10, 2025, 14:00 PM -
DAGDraw: A Responsive and Modern Directed Acyclic Graph Drawing Tool for Causal Inference and Transportability Analysis
Mar 10, 2025, 14:00 PM -
Moving Beyond Partitioned Survival Models in Oncology Submissions: Incorporation of Canada's Drug Agency Guidance on Model Structure
Mar 10, 2025, 14:00 PM -
Real-World Evidence in FDA and EMA Regulatory Reviews: Insights on Its Role in Submission Packages and Approvals
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization Costs in People With Cognitive Impairment Associated With Schizophrenia: A US Non-Interventional Cohort Study of Real World Data
Mar 10, 2025, 14:00 PM -
Long-Term Cost-Effectiveness of a Mobile Health Intervention Delivered by Clinical Pharmacists and Community Health Workers for Type 2 Diabetes Management
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Health Care Interventions in Patients with Chronic Rhinosinusitis with Nasal Polyps: A Systematic Literature Review
Mar 10, 2025, 14:00 PM -
Psychometric Evaluation of the ASCOT-SCT4, a Preference-Based Quality of Life Instrument for Social Care Service Users in Hong Kong: An Application of Item Response Theory
Mar 10, 2025, 14:00 PM
